MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0086378
Atrey Pharmaceuticals Private Limited - fmcg in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.76 Cr
▲ 36% YoY
Net profit · FY 2025
₹1.66 Lakh
Net margin 0.2%
EBITDA · FY 2025
₹41.61 Lakh
EBITDA margin 5.4%
Authorised capital
₹29 Lakh
Registered with MCA
Paid-up capital
₹29 Lakh
Issued & subscribed
Open charges
₹2.88 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
About Atrey Pharmaceuticals Private Limited
Data last updated:
Atrey Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the cosmetics and makeup products segment of the FMCG sector. It was incorporated on 26 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2013PTC074736. Its GSTIN is 24AAFCC2268J1ZO (Gujarat).
The company has an authorised share capital of ₹29 Lakh and a paid-up capital of ₹29 Lakh. It was formerly known as Coscare India Private Limited. It is led by directors Minish Shantilal Shah and Naman Minish Shah.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Paldi Kankaj, Ahmedabad, Gujarat, India – 382425.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.76 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹1.66 Lakh (net margin 0.2%) and EBITDA of ₹41.61 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 11% over five years.
The company is associated with 2 brands: Vedaone and Atrey Pharmaceuticals. As per MCA filings, the company has open charges of ₹2.88 Cr on record.
Atrey Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0086378). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website atreypharma.com.
Company details
CIN U24100GJ2013PTC074736
Registration Number 074736
Incorporation Date 26 April 2013
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0086378
Recognitions & Rankings of Atrey Pharmaceuticals
Contact details
Atrey Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its website is atreypharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPaldi Kankaj, Ahmedabad, Gujarat, India – 382425
- IndustryFMCG, Cosmetics & Makeup Products
To see the full contact details of Atrey Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Atrey Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Atrey Pharmaceuticals operates two associated brands: Vedaone and Atrey Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Serves as a brand offering a range of wellbeing products for consumers. | vedaoneglobal.com | |
| Manufacturing of Ayurvedic and herbal products in India. | atreypharma.com |
Business activity
The main business activity of Atrey Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Atrey Pharmaceuticals Private Limited, buy the company report.
Financials of Atrey Pharmaceuticals Private Limited
FY 2025 filings availableAtrey Pharmaceuticals Private Limited reported revenue of ₹7.76 Cr (up 36% YoY) for FY 2025.
Revenue · FY 2025
₹7.76 Cr ▲ 36%
Net profit · FY 2025
₹1.66 Lakh margin 0.2%
EBITDA · FY 2025
₹41.61 Lakh margin 5.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 18%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 14%
5 years · compounded
▼ 3%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 36% growth in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹41.61 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Atrey Pharmaceuticals Private Limited, buy the company report.
Board of directors of Atrey Pharmaceuticals Private Limited
Atrey Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Minish Shantilal Shah Also directs: Terranova Packtech Private Limited, Atrey Wellness Private Limited | Director | 26 Apr 2013 | 13 Years 6 Months | Current |
| Naman Minish Shah Also directs: Terranova Packtech Private Limited, Atrey Wellness Private Limited | Director | 26 Apr 2013 | 13 Years 6 Months | Current |
Peer comparison
Atrey Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| DNS Drugs & Pharmaceuticals Private Limited | ₹7.79 Cr (FY 2024) | 15.0% | Dombivli, Maharashtra, India | |||
| Hapdco Herbals Private Limited | ₹7.78 Cr (FY 2025) | 8.0% | Noida, Uttar Pradesh, India | |||
| Atrey Pharmaceuticals Private Limitedthis company | ₹7.76 Cr (FY 2025) | ₹1.66 Lakh | 0.2% | 36.0% | Ahmedabad, Gujarat, India | |
| Lexmark Pharmaceuticals Private Limited | ₹7.76 Cr (FY 2025) | -8.0% | Unjha, Gujarat, India | |||
| Rebrace Pharmaceuticals Private Limited | ₹7.71 Cr (FY 2024) | 55.0% | Bishnupur, West Bengal, India |
To see the full peer comparison of Atrey Pharmaceuticals Private Limited, buy the company report.
Auditor
Atrey Pharmaceuticals Private Limited is audited by K D N & Associates LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K D N & Associates LLP | FY 2023 | 131655W/W100691 |
Shareholding
The shareholding of Atrey Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Atrey Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.88 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Mar 2022 | 100546383 | Sidbi | ₹17.68 Lakh | Open | |
| 18 Aug 2020 | 100367192 | Sidbi | ₹35.33 Lakh | Open | |
| 17 Apr 2020 | 100362893 | Sidbi | ₹11.86 Lakh | Open | |
| 26 Jun 2019 | 100271132 | Sidbi | ₹18 Lakh | Open | |
| 29 Jan 2018 | 100153601 | Sidbi | ₹85 Lakh | Open |
To see the full charge records of Atrey Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
No court or tribunal cases involving Atrey Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Atrey Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Atrey Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCC2268J1ZO | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Atrey Pharmaceuticals Private Limited, buy the company report.
Recent activity
Atrey Pharmaceuticals Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Shah Minish Hina ceased to be Director on 07 Jun 2021.
AGM
Atrey Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Atrey Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Sidbi amounted to Rs. 17.68 Lakh with Charge ID 100546383 was registered on 15 Mar 2022.
Ceased
Shah Minish Hina ceased to be Director.
Ceased
Stuti Naman Shah ceased to be Director.
Ceased
Shantanu Minish Shah ceased to be Director.
Charges
A charge with Sidbi of Rs. 35.33 Lakh registered on 18 Aug 2020 with Charge ID 100367192 was modified on 21 Aug 2020.
Charges
A charge with Sidbi of Rs. 11.86 Lakh registered on 17 Apr 2020 with Charge ID 100362893 was modified on 21 Aug 2020.
Charges
A charge with Sidbi amounted to Rs. 35.33 Lakh with Charge ID 100367192 was registered on 18 Aug 2020.
Charges
A charge with Sidbi amounted to Rs. 11.86 Lakh with Charge ID 100362893 was registered on 17 Apr 2020.
Charges
A charge with Sidbi amounted to Rs. 18.00 Lakh with Charge ID 100271132 was registered on 26 Jun 2019.
Charges
A charge with Sidbi of Rs. 85.00 Lakh registered on 29 Jan 2018 with Charge ID 100153601 was modified on 26 Jun 2019.
5 earlier events are in the company report.
Frequently asked questions
Atrey Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in cosmetics and makeup products, within the FMCG industry. It was incorporated on 26 April 2013 (13+ years old) and is registered under CIN U24100GJ2013PTC074736.
Atrey Pharmaceuticals has 2 current directors:
- Minish Shantilal Shah - Director
- Naman Minish Shah - Director
The latest financial statements of Atrey Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Atrey Pharmaceuticals is 24AAFCC2268J1ZO, registered in Gujarat.
The CIN (Corporate Identification Number) of Atrey Pharmaceuticals is U24100GJ2013PTC074736. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Atrey Pharmaceuticals was incorporated on 26 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Atrey Pharmaceuticals by revenue are DNS Drugs & Pharmaceuticals Private Limited, Hapdco Herbals Private Limited, Lexmark Pharmaceuticals Private Limited, Rebrace Pharmaceuticals Private Limited, all in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (wholesale trading).
Shah Minish Hina ceased to be Director on 07 Jun 2021. Stuti Naman Shah ceased to be Director on 07 Jun 2021. Shantanu Minish Shah ceased to be Director on 20 May 2021. Atrey Pharmaceuticals has 5 board changes on record in total.
Yes, Atrey Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0086378).
Atrey Pharmaceuticals can be reached through the website atreypharma.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Atrey Pharmaceuticals is at Paldi Kankaj, Ahmedabad, Gujarat, India – 382425.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages